Naringenin ameliorates streptozotocin-induced diabetic rat renal impairment by downregulation of TGF-β1 and IL-1 via modulation of oxidative stress correlates with decreased apoptotic events

References

• Allister EM, Borradaile NM, Edwards JY, Huff MW et al. 2005a. Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes. Diabetes 54:1676–1683.
   PubMed Web of Science ®Google Scholar
• Allister EM, Borradaile NM, Edwards JY, et al. 2005b. Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the Citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes. J Lipid Res. 49:2218–2229.
   Web of Science ®Google Scholar
• Al-Shamaony L, Al-Khazaraji SM, Twaiji IA. 1994. Hypoglycaemic effect of Artemisia herba alba. II. Effect of a valuable extract on some blood parameters in diabetic animals. J Ethnopharmacol. 43:167–171.
   PubMed Web of Science ®Google Scholar
• Andrade L, Vieira JM, Safirstein R. 2000. How cells die counts. AM J Kidney Dis. 36:662–668.
   PubMed Web of Science ®Google Scholar
• Ayodele OE, Alebiosu CO, Salako BL. 2004. Diabetic nephropathy – a review of the natural history, burden, risk factors and treatment. J Natl Med Assoc. 96:1445–1454.
   PubMed Web of Science ®Google Scholar
• Baynes JW. 1991. Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412.
   PubMed Web of Science ®Google Scholar
• Bonnefont D. 2002. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 5:561–568.
   PubMed Web of Science ®Google Scholar
• Buege JA, Aust SD. 1984. Microsomal lipid peroxidation. Meth Enzymol. 105:302–310.
   Google Scholar
• Cochrane SM, Robinson GB. 1995. In vitro glycation of glomerular basement membrane alters its permeability: a possible mechanism in diabetic complications. FEBS Lett. 375:41–44.
   PubMed Web of Science ®Google Scholar
• Erin EM, Assini JM, Sutherland BG, et al. 2011. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice. Arterioscler Thromb Vasc Biol. 30:742–748.
   Web of Science ®Google Scholar
• Evans JL, Goldfine ID, Maddux BA, et al. 2002. Oxidative stress and stress activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 23:599–622.
   PubMed Web of Science ®Google Scholar
• Forbes JM, Coughlan MT, Cooper ME. 2008. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57:1446–1454.
   PubMed Web of Science ®Google Scholar
• Goldfarb S, Ziyadeh FN. 2001. TGF-beta: a crucial component of the pathogenesis of diabetic nephropathy. Trans Am Clin Climatol Assoc. 112:27–33.
   PubMedGoogle Scholar
• Goldwasser J, Cohen PY, Lin W, Kitsberg D, et al. 2011. Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism. J Hepatol. 55:963–971.
   PubMed Web of Science ®Google Scholar
• Goldwasser J, Cohen PY, Yang E, et al. 2010. Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARalpha, PPARgamma and LXRalpha. PLoS One 5:e12399.
   PubMed Web of Science ®Google Scholar
• Hertog MGL, Hollman PCH, Van De Putte B. 1993. Content of potentially anticarcinogenic flavonoids of tea infusions, wines and fruit juices. J Agric Food Chem. 41:1242–1246.
   Web of Science ®Google Scholar
• Jin R, Chow VT, Tan PH, et al. 2002. Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis 23:81–86.
   PubMed Web of Science ®Google Scholar
• Johansson LH, Hakan Borg LA. 1988. A spectrophotometric method for determination of catalase activity in small tissue samples. Anal Biochem. 174:331–336.
   PubMed Web of Science ®Google Scholar
• Jung DS, Lee SH, Kwak SH, et al. 2012. Apoptosis occurs differentially according to glomerular size in diabetic kidney disease. Nephrol Dial Transplant. 27:259–266.
   PubMed Web of Science ®Google Scholar
• Jung UJ, Kim HJ, Lee JS, et al. 2003. Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects. Clin Nutr. 22:561–568.
   PubMed Web of Science ®Google Scholar
• Kerr JF, Gobe GC, Winterford CM, et al. 1995. Anatomical methods in cell death. Methods Cell Biol. 46:1–27.
   PubMed Web of Science ®Google Scholar
• Kim SY, Kim HJ, Lee MK, et al. 2006. Naringin time dependently lowers hepatic cholesterol biosynthesis and plasma cholesterol in rats fed high-fat and high-cholesterol diet. J Med Food. 9:582–586.
   PubMed Web of Science ®Google Scholar
• Klein R. 1995. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18:258–268.
   PubMed Web of Science ®Google Scholar
• Kurowska E, Borradaile N, Spence JD, et al. 2000. Hypocholesterolemic effects of dietary citrus juices in rabbits. Nutr Res. 20:121–129.
   Web of Science ®Google Scholar
• Kurowska EM, Manthey JA, Casaschi A, et al. 2004. Modulation of HepG2 Cell net apolipoprotein B secretion by the Citrus polymethoxyflavone, tangeretin. Lipids 39:143–115.
   PubMed Web of Science ®Google Scholar
• Masiello P, Broca C, Gross R, et al. 1998. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47:224–229.
   PubMed Web of Science ®Google Scholar
• Mclennan SV, Hefernan S, Wright L. 1991. Changes in hepatic glutathione metabolism in diabetes. Diabetes 40:344–348.
   PubMed Web of Science ®Google Scholar
• Mullarkey CJ, Edelstein D, Brownlee L. 1990. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun. 173:932–939.
   PubMed Web of Science ®Google Scholar
• Nagata S. 1997. Apoptosis by death factor. Cell 88:355–365.
   PubMed Web of Science ®Google Scholar
• Navarro JF, Milena FJ, Mora C, et al. 2006. Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration. Am J Nephrol. 26:562–570.
   PubMed Web of Science ®Google Scholar
• Nishio E, Watanabe Y. 1997. Transforming growth factor beta is a modulator of platelet-derived growth factor action in vascular smooth muscle cells: a possible role for catalase activity and glutathione peroxidase activity. Biochem Biophys Res Commun. 232:1–4.
   PubMed Web of Science ®Google Scholar
• Obineche EN, Mensah-Brown E, Chandranath SI, et al. 2001. Morphological changes in the rat kidney following long-term diabetes. Arch Physiol Biochem. 109:241–245.
   PubMedGoogle Scholar
• Pagila DE, Valentine WN. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 70:158–169.
   PubMed Web of Science ®Google Scholar
• Palsamy P, Subramanian S. 2011. Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochim Biophys Acta 1812:719–731.
   PubMed Web of Science ®Google Scholar
• Parinandi NL, Thompson EW, Schmid HHO. 1990. Diabetic heart and kidney exhibit increased resistance to lipid peroxidation. Biochim Biophys Acta. 1047:63–69.
   PubMed Web of Science ®Google Scholar
• Ramachandran A, Snehalata C. 2009. Current scenario of diabetes in India. J Diabetes 1:18–28.
   PubMed Web of Science ®Google Scholar
• Rauscher FM, Ruth A, Watkins JB. 2001. Effects of isoeugenol on oxidative stress pathways in normal and streptozotocin induced diabetic rats. J Biochem Mol Toxicol. 15:159–164.
   PubMed Web of Science ®Google Scholar
• Ravi K, Ramachandran B, Subramanian S. 2004. Protective effect of Eugenia jambolana seed kernel on tissue antioxidants in streptozotocin-induced diabetic rats. Biol Pharm Bull. 27:1212–1217.
   PubMed Web of Science ®Google Scholar
• Reddi AS, Bollineni JS. 1997. Renal cortical expression of mRNAs for antioxidant enzymes in normal and diabetic rats. Biochem Biophys Res Commun. 235:598–601.
   PubMed Web of Science ®Google Scholar
• Reddi AS, Davalos RA. 1990. Diabetic nephropathy. An update. Arch Intern Med. 150:31–43.
   PubMedGoogle Scholar
• Remuzzi G, Schieppati A, Ruggenenti P. 2002. Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med. 346:1145–1151.
   PubMed Web of Science ®Google Scholar
• Renugadevi J, Prabu SM. 2009. Naringenin protects against cadmium-induced oxidative renal dysfunction in rats. Toxicology 256:128–134.
   PubMed Web of Science ®Google Scholar
• Roy S, Rahaman N, Ahmed F, et al. 2013. Naringenin attenuates testicular damage, germ cell death and oxidative stress in streptozotocin induced diabetic rats. J Appl Biomed. 11:195–208.
   Web of Science ®Google Scholar
• Salahudeen AK, Kanji V, Reckelhoff JF, Schimdt JM. 1997. Pathogenesis of diabetic nephropathy: a radical approach. Nephrol Dial Transplant 12:664–668.
   PubMed Web of Science ®Google Scholar
• Sassy-Prigent C, Heudes D, Jouquey S, et al. 2000. Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 49:466–475.
   PubMed Web of Science ®Google Scholar
• Schelling JR, Cleveland RP. 1999. Involvement of Fas-dependent apoptosis in renal tubular epithelial cell deletion in chronic renal failure. Kidney Int. 56:1313–1316.
   PubMed Web of Science ®Google Scholar
• Sharma K, Jin Y, Guo J, et al. 1996. Neutralization of TGF beta by anti TGF beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ induced diabetic mice. Diabetes 45:522–530.
   PubMed Web of Science ®Google Scholar
• Shulman M, Cohen M, Soto-Gutierrez A, et al. 2011. Enhancement of naringenin bioavailability by complexation with hydroxypropoyl-β-cyclodextrin. PLoS One 6:e18033.
   PubMed Web of Science ®Google Scholar
• Strain JJ. 1991. Disturbances of micronutrient and antioxidant status in diabetes. Proc Nutr Soc. 50:591–604.
   PubMed Web of Science ®Google Scholar
• Sugiyama H, Kashihara N, Makino H, et al. 1996. Apoptosis in glomerular sclerosis. Kidney Int. 49:103–111.
   PubMed Web of Science ®Google Scholar
• Wagener D, Dekker JH, Berden A, et al. 2009. The role of reactive oxygen species in apoptosis of the diabetic kidney. Diab Apop 14:1451–1458.
   Google Scholar
• Wild S, Roglic G, Green A, et al. 2004. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053.
   PubMed Web of Science ®Google Scholar
• Yamagishi S, Imaizumi T. 2005. Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy. Curr Pharm Des. 11:2279–2299.
   PubMed Web of Science ®Google Scholar
• Ziyadeh FN, Hoffman BB, Han DC, et al. 2000. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 97:8015–8020.
   PubMed Web of Science ®Google Scholar